|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sarantis P, Koustas E, Papadimitropoulou
A, Papavassiliou AG and Karamouzis MV: Pancreatic ductal
adenocarcinoma: Treatment hurdles, tumor microenvironment and
immunotherapy. World J Gastrointest Oncol. 12:173–181. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seok JY and Kim YB: Sarcomatoid
hepatocellular carcinoma. Korean J Hepatol. 16:89–94. 2010.(In
Korean). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luchini C, Capelli P and Scarpa A:
Pancreatic ductal adenocarcinoma and its variants. Surg Pathol
Clin. 9:547–560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bazzichetto C, Luchini C, Conciatori F,
Vaccaro V, Di Cello I, Mattiolo P, Falcone I, Ferretti G, Scarpa A,
Cognetti F and Milella M: Morphologic and Molecular landscape of
pancreatic cancer variants as the basis of new therapeutic
strategies for precision oncology. Int J Mol Sci. 21:88412020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Higashi M, Takao S and Sato E: Sarcomatoid
carcinoma of the pancreas: A case report with immunohistochemical
study. Pathol Int. 49:453–456. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De la Riva S, Muñoz-Navas MA, Betés M,
Súbtil JC, Carretero C and Sola JJ: Sarcomatoid carcinoma of the
pancreas and congenital choledochal cyst. Gastrointest Endosc.
64:1005–1006. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yao J, Qian JJ, Zhu CR, Bai DS and Miao Y:
Laparoscopic left pancreatectomy for pancreatic sarcomatoid
carcinoma: A case report and review of the literature. Oncol Lett.
6:568–570. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren CL, Jin P, Han CX, Xiao Q, Wang DR,
Shi L, Wang DX and Chen H: Unusual early-stage pancreatic
sarcomatoid carcinoma. World J Gastroenterol. 19:7820–7824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kane JR, Laskin WB, Matkowskyj KA, Villa C
and Yeldandi AV: Sarcomatoid (spindle cell) carcinoma of the
pancreas: A case report and review of the literature. Oncol Lett.
7:245–249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu BC, Wang C, Yu JH, Shen ZH and Yang JH:
A huge adenosquamous carcinoma of the pancreas with sarcomatoid
change: An unusual case report. World J Gastroenterol.
20:16381–16386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yepuri N, Pruekprasert N and Naous R:
High-grade malignant pancreatic neoplasm with sarcomatoid features.
AME Case Rep. 2:392018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie Y, Xiang Y, Zhang D, Yao X, Sheng J,
Yang Y and Zhang X: Sarcomatoid carcinoma of the pancreas: A case
report and review of the literature. Mol Med Rep. 18:4716–4724.
2018.PubMed/NCBI
|
|
15
|
Bukhari N and Joudeh A: Early stage
anaplastic sarcomatoid carcinoma of the pancreas, a case report. Am
J Case Rep. 20:597–601. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou DK, Gao BQ, Zhang W, Qian XH, Ying LX
and Wang WL: Sarcomatoid carcinoma of the pancreas: A case report.
World J Clin Cases. 7:236–241. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toledo PF, Berger Z, Carreño L, Cardenas
G, Castillo J and Orellana O: Sarcomatoid carcinoma of the
pancreas-a rare tumor with an uncommon presentation and course: A
case report and review of literature. World J Clin Cases.
9:3716–3725. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lim HJ, Kang HS, Lee JE, Min JH, Shin KS,
You SK and Kim KH: Sarcomatoid carcinoma of the
pancreas-multimodality imaging findings with serial imaging
follow-up: A case report and review of literature. World J Clin
Cases. 9:3102–3113. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harada Y, Sakai A, Ikegawa T, Shiomi H,
Masuda A and Kodama Y: Pancreatic sarcomatoid carcinoma with
intraductal growth protruding from the papilla of vater. Am J
Gastroenterol. 117:19002022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang ML, Sabatino ME, Castillo CFD,
Mattia AR and Chebib I: Cytologic, histologic, and molecular
features of pancreatic sarcomatoid undifferentiated carcinoma with
heterologous osteosarcomatous transformation. Diagn Cytopathol.
51:E164–E169. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen LL, Chen J, Bu P, Chen CW and Xiang
XX: Two cases of sarcomatoid pancreatic carcinoma. Chin J
Gastroenterol Hepatol. 23:837–838. 2014.
|
|
22
|
Hu QL, Li HQ and Xia TY: A case of
sarcomatoid carcinoma of the pancreas. Shijie Huaren Xiaohua Zazhi.
23:707–710. 2015.
|
|
23
|
Zhao ZB, Ji Y and Kong HF: Pancreatic
sarcomatoidcarcinoma with liver metastasis: A case report. Chin J
Geriatr. 37:225–226. 2018.(In Chinese).
|
|
24
|
Jiang YS, Tao LY, Yang MW, He RZ, Shen Y
and Sun YW: A case of sarcomatoid carcinoma of the pancreas. Chin J
Pract Surg. 39:879–880. 2019.(In Chinese).
|
|
25
|
Ren PT: Two cases of sarcomatoid carcinoma
of the pancreas. Chin J Gen Srug. 34:366–367. 2019.(In
Chinese).
|
|
26
|
Kimura T, Fujimoto D, Togawa T, Ishida M,
Iida A, Sato Y and Goi T: Sarcomatoid carcinoma of the pancreas
with rare long-term survival: A case report. World J Surg Oncol.
18:1052020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kimura T, Togawa T, Iida A, Noriki S, Sato
Y and Goi T: Does cellular senescence play an important role in the
prognosis of sarcomatoid carcinoma of the pancreas? World J Surg
Oncol. 19:792021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blair AB, Burkhart RA, Griffin JF, Miller
JA, Weiss MJ, Cameron JL, Wolfgang CL and He J: Long-term survival
after resection of sarcomatoid carcinoma of the pancreas: An
updated experience. J Surg Res. 219:238–243. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gkountakos A, Simbolo M, Bariani E, Scarpa
A and Luchini C: Undifferentiated sarcomatoid carcinoma of the
pancreas: From histology and molecular pathology to precision
oncology. Int J Mol Sci. 23:12832022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clark CJ, Graham RP, Arun JS, Harmsen WS
and Reid-Lombardo KM: Clinical outcomes for anaplastic pancreatic
cancer: A population-based study. J Am Coll Surg. 215:627–634.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guarino M, Tricomi P, Giordano F and
Cristofori E: Sarcomatoid carcinomas: Pathological and
histopathogenetic considerations. Pathology. 28:298–305. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
WHO Classification of Tumours Editorial
Board, . Digestive System Tumours. WHO classification of tumours.
5th edition. International Agency for Research on Cancer; Lyon:
2019
|
|
33
|
Li J, Wei T, Zhang J, Wei S, Chen Q, Chen
BW, Zhou Y, Wen L, Qin H, Bai X and Liang T: Carcinosarcoma of the
pancreas: Comprehensive clinicopathological and molecular
characterization. HPB (Oxford). 22:1590–1595. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruess DA, Kayser C, Neubauer J,
Fichtner-Feigl S, Hopt UT and Wittel UA: Carcinosarcoma of the
pancreas: Case report with comprehensive literature review.
Pancreas. 46:1225–1233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thompson L, Chang B and Barsky SH:
Monoclonal origins of malignant mixed tumors (carcinosarcomas).
Evidence for a divergent histogenesis. Am J Surg Pathol.
20:277–285. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cantrell LA, Blank SV and Duska LR:
Uterine carcinosarcoma: A review of the literature. Gynecol Oncol.
137:581–588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van den Berg W, Tascilar M, Offerhaus GJ,
Albores-Saavedra J, Wenig BM, Hruban RH and Gabrielson E:
Pancreatic mucinous cystic neoplasms with sarcomatous stroma:
Molecular evidence for monoclonal origin with subsequent divergence
of the epithelial and sarcomatous components. Mod Pathol. 13:86–91.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Y and Weinberg RA:
Epithelial-to-mesenchymal transition in cancer: Complexity and
opportunities. Front Med. 12:361–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cantelli G, Crosas-Molist E, Georgouli M
and Sanz-Moreno V: TGFBeta-induced transcription in cancer. Semin
Cancer Biol. 42:60–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Massagué J: TGFbeta signalling in context.
Nat Rev Mol Cell Biol. 13:616–630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Arteaga CL: Inhibition of TGFbeta
signaling in cancer therapy. Curr Opin Genet Dev. 16:30–37. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kang Y, He W, Tulley S, Gupta GP,
Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL and
Massagué J: Breast cancer bone metastasis mediated by the Smad
tumor suppressor pathway. Proc Natl Acad Sci USA. 102:13909–13914.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Boström AK, Möller C, Nilsson E, Elfving
P, Axelson H and Johansson ME: Sarcomatoid conversion of clear cell
renal cell carcinoma in relation to epithelial-to-mesenchymal
transition. Hum Pathol. 43:708–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lien HC, Lee YH, Juang YL and Lu YT:
Fibrillin-1, a novel TGF-beta-induced factor, is preferentially
expressed in metaplastic carcinoma with spindle sarcomatous
metaplasia. Pathology. 51:375–383. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kawarada Y, Inoue Y, Kawasaki F, Fukuura
K, Sato K, Tanaka T, Itoh Y and Hayashi H: TGF-β induces p53/Smads
complex formation in the PAI-1 promoter to activate transcription.
Sci Rep. 6:354832016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Saitoh M: Epithelial-mesenchymal
transition is regulated at post-transcriptional levels by
transforming growth factor-β signaling during tumor progression.
Cancer Sci. 106:481–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Husain AN, Colby TV, Ordóñez NG, Krausz T,
Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs
AR, et al: Guidelines for pathologic diagnosis of malignant
mesothelioma: A consensus statement from the international
mesothelioma interest group. Arch Pathol Lab Med. 133:1317–1331.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shi HY, Xie J and Miao F: Pancreatic
carcinosarcoma: First literature report on computed tomography
imaging. World J Gastroenterol. 21:1357–1361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Watanabe M, Miura H, Inoue H, Uzuki M,
Noda Y, Fujita N, Yamazaki T and Sawai T: Mixed
osteoclastic/pleomorphic-type giant cell tumor of the pancreas with
ductal adenocarcinoma: Histochemical and immunohistochemical study
with review of the literature. Pancreas. 15:201–208. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mugaanyi J and Lu C, Huang J and Lu C:
Undifferentiated pancreatic carcinomas, clinical features and
therapeutic options: What we know. Cancers (Basel). 14:61022022.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Park W, Chawla A and O'Reilly EM:
Pancreatic cancer: A review. JAMA. 326:851–862. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ding Y, Shao Y, Na C, Yin JC, Hua H, Tao
R, Jiang Y, Hu R, He X, Miao C, et al: Genetic characterisation of
sarcomatoid carcinomas reveals multiple novel actionable mutations
and identifies KRAS mutation as a biomarker of poor prognosis. J
Med Genet. 59:10–17. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gkountakos A, Mafficini A, Lou E, Malleo
G, Salvia R, Calicchia M, Silvestris N, Racila E, Amin K, Veronese
N, et al: Genomic characterization of undifferentiated sarcomatoid
carcinoma of the pancreas. Hum Pathol. 128:124–133. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Iacobuzio-Donahue CA, Fu B, Yachida S, Luo
M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P,
et al: DPC4 gene status of the primary carcinoma correlates with
patterns of failure in patients with pancreatic cancer. J Clin
Oncol. 27:1806–1813. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Blackford A, Serrano OK, Wolfgang CL,
Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ,
Eshleman JR, et al: SMAD4 gene mutations are associated with poor
prognosis in pancreatic cancer. Clin Cancer Res. 15:4674–4679.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Agaimy A, Haller F, Frohnauer J, Schaefer
IM, Ströbel P, Hartmann A, Stoehr R and Klöppel G: Pancreatic
undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1
expression status define two subtypes. Mod Pathol. 28:248–260.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Waddell N, Pajic M, Patch AM, Chang DK,
Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, et al:
Whole genomes redefine the mutational landscape of pancreatic
cancer. Nature. 518:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lehrke HD, Graham RP, Mcwilliams RR,
Lam-Himlin DM, Smyrk TC, Jenkins S, Dong H and Zhang L:
Undifferentiated pancreatic carcinomas display enrichment for
frequency and extent of PD-L1 expression by tumor cells. Am J Clin
Pathol. 148:441–449. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Silvestris N, Argentiero A, Brunetti O,
Sonnessa M, Colonna F, Delcuratolo S, Luchini C, Scarpa A, Lonardi
S, Nappo F, et al: PD-L1 and Notch as novel biomarkers in
pancreatic sarcomatoid carcinoma: A pilot study. Expert Opin Ther
Targets. 25:1007–1016. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Halbrook CJ, Lyssiotis CA, Pasca di
Magliano M and Maitra A: Pancreatic cancer: Advances and
challenges. Cell. 186:1729–1754. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hermanek P and Wittekind C: Residual tumor
(R) classification and prognosis. Semin Surg Oncol. 10:12–20. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Shiihara M, Higuchi R, Izumo W, Furukawa T
and Yamamoto M: A comparison of the pathological types of
undifferentiated carcinoma of the pancreas. Pancreas. 49:230–235.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Imaoka H, Ikeda M, Maehara K, Umemoto K,
Ozaka M, Kobayashi S, Terashima T, Inoue H, Sakaguchi C, Tsuji K,
et al: Clinical outcomes of chemotherapy in patients with
undifferentiated carcinoma of the pancreas: A retrospective
multicenter cohort study. BMC Cancer. 20:9462020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Qian Y, Gong Y, Fan Z, Luo G, Huang Q,
Deng S, Cheng H, Jin K, Ni Q, Yu X and Liu C: Molecular alterations
and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol
Oncol. 13:1302020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zorde Khvalevsky E, Gabai R, Rachmut IH,
Horwitz E, Brunschwig Z, Orbach A, Shemi A, Golan T, Domb AJ, Yavin
E, et al: Mutant KRAS is a druggable target for pancreatic cancer.
Proc Natl Acad Sci USA. 110:20723–20728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhu H, Wei M, Xu J, Hua J, Liang C, Meng
Q, Zhang Y, Liu J, Zhang B, Yu X and Shi S: PARP inhibitors in
pancreatic cancer: Molecular mechanisms and clinical applications.
Mol Cancer. 19:492020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ashworth A: A synthetic lethal therapeutic
approach: Poly(ADP) ribose polymerase inhibitors for the treatment
of cancers deficient in DNA double-strand break repair. J Clin
Oncol. 26:3785–3790. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Serrano PE, Cleary SP, Dhani N, Kim PT,
Greig PD, Leung K, Moulton CA, Gallinger S and Wei AC: Improved
long-term outcomes after resection of pancreatic adenocarcinoma: A
comparison between two time periods. Ann Surg Oncol. 22:1160–1167.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Philips P, Kooby DA, Maithel S, Merchant
NB, Weber SM, Winslow ER, Ahmad S, Kim HJ, Scoggins CR, McMasters
KM and Martin RCG II: Grading using Ki-67 index and mitotic rate
increases the prognostic accuracy of pancreatic neuroendocrine
tumors. Pancreas. 47:326–331. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Strobel O, Hartwig W, Bergmann F, Hinz U,
Hackert T, Grenacher L, Schneider L, Fritz S, Gaida MM, Büchler MW
and Werner J: Anaplastic pancreatic cancer: Presentation, surgical
management, and outcome. Surgery. 149:200–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
